|
|||||
|
|
Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancer |
|
| Authors: | Stefan Madajewicz David M. Waterhouse Paul S. Ritch M. Qaseem Khan Donald J. Higby Cynthia G. Leichman Sandeep K. Malik Patricia Hentschel John F. Gill Luping Zhao Steven J. Nicol |
| Affiliation: | 1. Montefiore North Division Cancer Center, 600 E 233rd Street, Bronx, NY, 10466, USA 2. Oncology Hematology Care, Inc., Cincinnati, OH, USA 3. Medical College of Wisconsin, Milwaukee, WI, USA 4. Marshfield Clinic, Marshfield, WI, USA 5. Baystate Medical Center, Springfield, MA, USA 6. Comprehensive Cancer Center, Palm Springs, CA, USA 7. Stony Brook Cancer Center, Stony Brook, NY, USA 8. Lilly USA, LLC, Indianapolis, IN, USA |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed SpringerLink 等数据库收录！ | |